Correction: Factors associated with longer brain metastasis-free survival in limited-disease small-cell lung cancer who underwent concurrent chemoradiotherapy, a retrospective analysis

Key Points

• Longer brain metastasis-free survival is linked to specific factors in small-cell lung cancer patients.
• Key metric highlights a correlation between treatment strategies and survival timelines.
• Retrospective analysis showcases survival outcomes among those receiving concurrent chemoradiotherapy.
• Implications suggest potential for improved treatment approaches based on identified factors.

Abstract